Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial (Q43060810)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 May 2010
edit
Language Label Description Also known as
English
Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial
scientific article published on 18 May 2010

    Statements

    Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit